These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6887009)

  • 1. Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
    Chan PS; Cervoni P; Ronsberg MA; Accomando RC; Quirk GJ; Scully PA; Lipchuck LM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):726-32. PubMed ID: 6887009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CL 115,347 (DHV-PGE2 ME): a new orally and topically active prostaglandin antihypertensive agent.
    Cervoni P; Chan PS; Lai FM; Birnbaum JE
    Fed Proc; 1983 Feb; 42(2):157-61. PubMed ID: 6571821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
    Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins and congeners, 29. (16RS)-(+/-)-15-Deoxy-16-hydroxy-16-vinyl-prostaglandin E2, an orally and transdermally active hypotensive agent of prolonged duration.
    Birnbaum JE; Cervoni P; Chan PS; Chen SM; Floyd MB; Grudzinskas CV; Weiss J; Dessy F
    J Med Chem; 1982 May; 25(5):492-4. PubMed ID: 7086833
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of action of a new prostaglandin antihypertensive, viprostol [CL 115 347; (dl)-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl-prostaglandin E2 methyl ester]: (II). Effects on the adrenergic nervous system.
    Chan PS; Cervoni P; Accomando RC; Quirk GJ; Ronsberg MA
    J Hypertens; 1986 Dec; 4(6):749-57. PubMed ID: 2880911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of a new prostaglandin antihypertensive, viprostol [CL 115 347; (dl)-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl-prostaglandin E2 methyl ester]: (I). Vasodilation.
    Chan PS; Cervoni P; Scully PA; Ronsberg MA; Accomando RC
    J Hypertens; 1986 Dec; 4(6):741-7. PubMed ID: 3029218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the antihypertensive prostaglandin analog CL 115,347 on cardiac output distribution in the spontaneously hypertensive rat.
    Crandall DL; Goldstein BM; Gabel R; Lizzo FH; Cervoni P
    J Cardiovasc Pharmacol; 1985; 7(5):996-1002. PubMed ID: 2413314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic stable orally and transdermally long-acting prostaglandin E2 (PGE2) congener (viprostol; CL 115,347) and prostacyclin congener (CL 115,999) as antihypertensive agents.
    Cervoni P; Chan PS
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():331-4. PubMed ID: 2526492
    [No Abstract]   [Full Text] [Related]  

  • 11. The diuretic effects of CL 115,129 (d,1-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl-prostaglandin E2) and l-prostaglandin E2 in dogs.
    Quirk GJ; Chan PS; Cervoni P; Emma J
    Prostaglandins Leukot Med; 1984 Feb; 13(2):219-26. PubMed ID: 6585843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
    Nakajima T; Shinohara T; Yaoka O; Fukunari A; Shinagawa K; Aoki K; Katoh A; Yamanaka T; Setoguchi M; Tahara T
    J Pharmacol Exp Ther; 1992 May; 261(2):730-6. PubMed ID: 1578381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.
    Roesler JM; McCafferty JP; DeMarinis RM; Matthews WD; Hieble JP
    J Pharmacol Exp Ther; 1986 Jan; 236(1):1-7. PubMed ID: 2867209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 analogue elicits renal and hormonal compensatory mechanisms in human hypertension.
    Given BD; Vita NA; Black HR; Francis C; Lasseter K; Morray RL; Mickiewicz C; Akester J; Koury K; Dzau VJ
    Hypertension; 1986 Jun; 8(6):489-96. PubMed ID: 3519451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Mitch S; Powell JR; Petrillo W; Cushman DW
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):139-46. PubMed ID: 1696656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of SC-56525, a potent, orally active renin inhibitor, in salt-depleted and renal hypertensive dogs.
    McMahon EG; Yang PC; Babler MA; Bittner SE; Suleymanov OD; Cain-Janicki KJ; Bedell LJ; Hanson GJ; Cook CS
    Hypertension; 1995 Jul; 26(1):95-100. PubMed ID: 7607739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.